

What Next | Daily News and Analysis
Slate Podcasts
The problem with the news right now? It’s everywhere. And each day, it can feel like we’re all just mindlessly scrolling. It’s why we created What Next. This short daily show is here to help you make sense of things. When the news feels overwhelming, we’re here to help you answer: What next? Look for new episodes every weekday morning.Get more of What Next with Slate Plus! Join for exclusive bonus episodes of What Next and ad-free listening on all your favorite Slate podcasts. Subscribe from the What Next show page on Apple Podcasts or Spotify, or visit slate.com/whatnextplus for access wherever you listen.
Episodes
Mentioned books

Apr 2, 2023 • 37min
TBD | Seeking Asylum Via App
CBP One, U.S. Customs and Border Protection's app that is supposed to make crossing the border more efficient, is littered with bugs. But even a perfectly functional smartphone app would pose problems for people seeking asylum on the southern U.S. border. Guest: Arelis Hernández, Washington Post reporterGia Del Pino, director of communications at the Kino Border InitiativeFelicia Rangel Samponaro, director of the Sidewalk SchoolHost: Lizzie O’LearyIf you enjoy this show, please consider signing up for Slate Plus. Slate Plus members get benefits like zero ads on any Slate podcast, bonus episodes of shows like Slow Burn and Dear Prudence—and you’ll be supporting the work we do here on What Next TBD. Sign up now at slate.com/whatnextplus to help support our work. Learn more about your ad choices. Visit megaphone.fm/adchoices

Mar 31, 2023 • 29min
TBD | When A.I. Denies Your Health Care
As Medicare Advantage plans have increased their reliance on software to determine what their customers require—and, therefore, receive—elderly patients are being denied coverage for care they need. What happens when an algorithm — not a doctor — decides how much care you need and it’s not enough?Guest: Casey Ross, national technology correspondent at STATHost: Emily PeckIf you enjoy this show, please consider signing up for Slate Plus. Slate Plus members get benefits like zero ads on any Slate podcast, bonus episodes of shows like Slow Burn and Dear Prudence—and you’ll be supporting the work we do here on What Next TBD. Sign up now at slate.com/whatnextplus to help support our work.Podcast production by Evan Campbell Learn more about your ad choices. Visit megaphone.fm/adchoices

Mar 30, 2023 • 31min
The Diagnosis Was Fatal. She Couldn't Get an Abortion.
Two weeks after Roe v. Wade was overturned, Lauren Hall found out the baby she was carrying had a fatal condition: her head and skull weren’t properly developing. Texas’s three overlapping bans on abortion forced her to fly to Washington to terminate the unviable pregnancy. With the Center for Reproductive Rights, she’s now one of five plaintiffs suing the state, so no one else will have to go through what she did.Guest: Lauren Hall, plaintiff suing the state of Texas over its abortion bans.If you enjoy this show, please consider signing up for Slate Plus. Slate Plus members get benefits like zero ads on any Slate podcast, bonus episodes of shows like Slow Burn and Amicus—and you’ll be supporting the work we do here on What Next. Sign up now at slate.com/whatnextplus to help support our work. Learn more about your ad choices. Visit megaphone.fm/adchoices

Mar 29, 2023 • 29min
March Madness Comes to Capitol Hill
Two years ago, the NCAA changed their rules to allow college athletes to make money from their “name, image and likeness.” It was a stop-gap measure at best, and some folks even want to see athletes gain employee status. But, the NCAA has taken to Capitol Hill today to try to prevent just that. Guest: Dan Murphy, staff writer at ESPN and author of Start By Believing.Spotify listeners, click here and follow What Next and to make sure you never miss an episode. Learn more about your ad choices. Visit megaphone.fm/adchoices

Mar 28, 2023 • 26min
Why Israelis Are Protesting
Israel ground to a halt on Monday after a series of massive protests against planned judicial reforms. Though Prime Minister Benjamin Netanyahu announced the reforms will be delayed, getting them passed is a top priority for his far-right coalition government. How can the government—and country—move forward?Guest: Dahlia Scheindlin, international political and strategic consultant and fellow at Century International in Tel Aviv.If you enjoy this show, please consider signing up for Slate Plus. Slate Plus members get benefits like zero ads on any Slate podcast, bonus episodes of shows like Slow Burn and Amicus—and you’ll be supporting the work we do here on What Next. Sign up now at slate.com/whatnextplus to help support our work. Learn more about your ad choices. Visit megaphone.fm/adchoices

Mar 27, 2023 • 28min
Will Crime Decide Chicago’s Mayoral Race?
In Chicago, a city plagued by recent crime concerns from its citizens, a progressive former Teachers Union organizer faces an opponent who has described himself in the past as “more of a Republican than a Democrat.” Guest: Gregory Pratt, Chicago Tribune reporter covering Mayor Lori Lightfoot and City Hall.If you enjoy this show, please consider signing up for Slate Plus. Slate Plus members get benefits like zero ads on any Slate podcast, bonus episodes of shows like Slow Burn and Amicus—and you’ll be supporting the work we do here on What Next. Sign up now at slate.com/whatnextplus to help support our work. Learn more about your ad choices. Visit megaphone.fm/adchoices

Mar 26, 2023 • 32min
TBD | Tesla’s Full Self-Driving Woes
Elon Musk has been promising fully self-driving Teslas to the public for years and the beta version of Full Self-Driving is already in over 300,000 cars. But as a recent recall attests, the software still isn’t ready to take the wheel—and Musk himself may be a big reason why. Guest: Faiz Siddiqui, tech reporter for the Washington PostHost: Lizzie O’LearyIf you enjoy this show, please consider signing up for Slate Plus. Slate Plus members get benefits like zero ads on any Slate podcast, bonus episodes of shows like Slow Burn and Dear Prudence—and you’ll be supporting the work we do here on What Next TBD. Sign up now at slate.com/whatnextplus to help support our work. Learn more about your ad choices. Visit megaphone.fm/adchoices

Mar 24, 2023 • 36min
TBD | The Case Against TikTok
To most of its 150 million American consumers, TikTok is a fun app. To some creators, TikTok is a job and their platform. But to members of the US government, TikTok is a national security risk. As the fight over TikTok’s future comes to Capitol Hill this week, what’s next for the embattled social media platform?Guest: Emily Baker-White, senior writer, tech reporter at ForbesHost: Lizzie O’LearyIf you enjoy this show, please consider signing up for Slate Plus. Slate Plus members get benefits like zero ads on any Slate podcast, bonus episodes of shows like Slow Burn and Dear Prudence—and you’ll be supporting the work we do here on What Next TBD. Sign up now at slate.com/whatnextplus to help support our work. Learn more about your ad choices. Visit megaphone.fm/adchoices

Mar 23, 2023 • 27min
Why Biden Broke his Promise on Drilling
Despite his campaign promises, President Biden has signed off on the Willow Project, an $8 billion plan to extract 600 million barrels of oil from public lands in Alaska. But how useful might this 30-year project be with the country continually prioritizing electric energy?Guest: Ben Lefebvre, energy reporter at Politico. If you enjoy this show, please consider signing up for Slate Plus. Slate Plus members get benefits like zero ads on any Slate podcast, bonus episodes of shows like Slow Burn and Amicus—and you’ll be supporting the work we do here on What Next. Sign up now at slate.com/whatnextplus to help support our work. Learn more about your ad choices. Visit megaphone.fm/adchoices

5 snips
Mar 22, 2023 • 25min
Why Is Adderall So Hard to Find?
Since last summer, it’s been difficult to fill an Adderall prescription. The shortage is driving some people to try other ADHD medications—causing shortages of those medications too—while others are sourcing their medication on the “gray market.” Why is such a common drug nowhere to be found?And why has the FDA been so mum on the subject? Guests: Ike Swetlitz, health journalist for Bloomberg NewsSheila McClear, writer for Los Angeles magazineIf you enjoy this show, please consider signing up for Slate Plus. Slate Plus members get benefits like zero ads on any Slate podcast, bonus episodes of shows like Slow Burn and Amicus—and you’ll be supporting the work we do here on What Next. Sign up now at slate.com/whatnextplus to help support our work. Learn more about your ad choices. Visit megaphone.fm/adchoices